HIGH RISK CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA GROUP TREATED WITH THE EORTC58951 PROTOCOL: RESULTS AND OUTCOME

被引：0
|
作者：
Medhaffar, M. [1 ]
机构：
[1] Hedi Chaker Hosp, Hematol, Sfax, Tunisia
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1609
引用
收藏
页码：642 / 642
页数：1
相关论文
共 50 条
  • [1] OUTCOME OF CORTICORESITANT PATIENTS TREATED WITH THE PEDIATRIC EORTC 58951 PROTOCOL FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Medhaffar, M.
    Frikha, I.
    Ajmi, N.
    Hdiji, S.
    Lakhal, A.
    Bellaaj, H.
    Kassar, O.
    Kammoun, L.
    Ben Othmen, T.
    Elloumi, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 493 - 493
  • [2] OUTCOME OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY THE EORTC 58951 PROTOCOL ABOUT 152 CASES
    Frikha, I.
    Medhaffar, M.
    Hdiji, S.
    Ajmi, N.
    Bellaaj, H.
    Sfaihi, L.
    Kassar, O.
    Kammoun, L.
    Hachicha, M.
    Elloumi, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 492 - 492
  • [3] LONG-TERM RESULTS OF EORTC 58951 PROTOCOL FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA
    Medhaffar, M.
    Frikha, I.
    Hadiji, S.
    Kassar, O.
    Sfaihi, L.
    Bellaj, H.
    Turki, F.
    Kammoun, L.
    Chabchoub, I.
    Ghorbel, M.
    Gargouri, L.
    Abdeljalil, N.
    Hachicha, M.
    Mahfoudh, A.
    Othmen, T.
    Elloumi, M.
    [J]. HAEMATOLOGICA, 2013, 98 : 501 - 501
  • [4] PRESENTATION AND OUTCOME OF CHILDREN WITH DOWN SYNDROME AND ACUTE LYMPHOBLASTIC LEUKEMIA IN THE EORTC CHILDREN'S LEUKEMIA GROUP PROTOCOL 58951
    Mondelaers, V.
    De Moerloose, B.
    Suciu, S.
    Ferster, A.
    Lutz, P.
    Uyttebroeck, A.
    Plantaz, D.
    Norton, L.
    Sirvent, N.
    Robert, A.
    Philippet, P.
    Mazingue, F.
    Yakouben, K.
    Munzer, M.
    Millot, F.
    Rohrlich, P.
    Baila, L.
    Bertrand, Y.
    Benoit, Y.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 260 - 260
  • [5] FAVORABLE OUTCOME FOR ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH EORTC 58951
    Aissaoui, L.
    Abdennebi, Y.
    Achour, M.
    Neji, H.
    Mansouri, R.
    Zarrouk, M.
    Kacem, K.
    Jeddi, R.
    Lakhal, R.
    Abid, H.
    Ali, Z.
    Meddeb, B.
    [J]. HAEMATOLOGICA, 2013, 98 : 501 - 501
  • [6] Predictors of methotrexate-induced toxicity and treatment outcome in patients with acute lymphoblastic leukemia treated with EORTC 58951 protocol
    Ben Mahmoud, L.
    Mdhaffar, M.
    Ammar, M.
    Ghozzi, H.
    Ahmed, H.
    Zouheir, S.
    Elloumi, M.
    Zeghal, K.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 71 - 71
  • [7] FOURTEEN YEARS EXPERIENCE WITH THE EORTC 58951 PROTOCOL FOR THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA
    Medhaffar, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 640 - 641
  • [8] Results of childhood acute lymphoblastic leukaemia treatment using EORTC 58881 and EORTC 58951 protocols
    Laatiri, M. A.
    Ben Moussa, f.
    Makhlouf, I.
    Bedoui, M.
    Zahra, K.
    Kortas, M.
    Khelif, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 457 - 457
  • [9] Epidemiology and response to treatement in child acute lymphoblastic leukemia treated by EORTC 58951
    Bedoui, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 529 - 529
  • [10] Impact of Age and Treatment Group in Childhood High Hyperdiploid Low Risk B-Cell Acute Lymphoblastic Leukemia (ALL): Results of the CLG-EORTC 58951 Study
    Clement, Laura
    Suciu, Stefan
    Luquet, Isabelle
    Ferster, Alina
    Yakouben, Karima
    Uytterbroeck, Anne
    Paillard, Catherine
    Sirvent, Nicolas
    Costa, Vitor
    De Moerloose, Barbara
    Mazingue, Francoise
    Plouvier, Emmanuel
    Munzer, Martine
    Poiree, Maryline
    Minckes, Odile
    Millot, Frederic
    Plantaz, Dominique
    Piette, Caroline
    Speleman, Frank
    Cave, Helene
    VanderWerff-TenBossch, Jutte
    Rohrlich, Pierre Simon
    Bertrand, Yves
    Benoit, Yves
    Plat, Genevieve
    [J]. BLOOD, 2016, 128 (22)
12345